AstraZeneca Pharma India and Sun Pharmaceutical Industries have formed an exclusive brand partnership to promote and distribute SZC for hyperkalaemia treatment under separate brands
The deal is expected to be announced at the White House on Friday, said the people, who spoke on condition of anonymity because the plans are not yet public
The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share dividend